Komori
Annual Securities Report6090Human Metabolome Technologies,Inc.Services

Annual Securities Report — FY2025

What Human Metabolome Technologies,Inc. reported for the period from 2025-07-01 to 2026-06-30.

How much it says
71Detailed
What moved here
33named for the first time
Its own wording
47terms
Which filing this is
35/ 35newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist

The annual securities report for the fiscal year from 1 July 2025 to 30 June 2026 was filed. It states that revenue and profit declined year on year and that the reporting segments were changed to a single segment, the contract metabolome analysis services business. It also describes capital expenditure plans for analytical instruments and other equipment at the Tsuruoka head office and IT systems and other equipment at the Tokyo office, as well as the acquisition of treasury shares and payment of a year-end dividend.

Komori's summary of this document, not the document's own words.
71Detailed
How much this filing saysA weighted roll-up of 12 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 37 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
96
Very detailed
Intensity of change
91
Very detailed
Strategic shift
70
Detailed
Capital movements
62
Detailed
Disclosure Gaps
0
Almost nothing
Concentration Risk
100
Very detailed
Future commitments
68
Detailed
Change in Risk
77
Very detailed
Financial and Capital Policy
100
Very detailed
Specificity of disclosure
53
Typical
Product portfolio
55
Typical
Technology Position
50
Typical
Confidence in Strategic Bets
R&D spend1億円Money spent making new things.
Cash left over1億円Cash from the business, less what went into equipment.
Spent on equipment91百万円Plants, machines — things meant to last.
Employees65Headcount at the end of this period.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.
Human Metabolome Technologies,Inc. — FY2025 | Komori